1. Armaroli P, Gallo F, Anghinoni E, Beccati D, Bellomi A, Brezzi S, Cariaggi MP, Carpanelli MC, Ciatto S, Consonni D, Dalla Palma P, Davi D, Giorgi Rossi P, Iossa A, Mancini E, Naldoni C, Polla E, Raggi P, Ronco G, Schincaglia P, Serafini M, Tomaino A, Vergini V, Zanier L, Segnan N (2005) Studio sulla frequenza del tumore della cervice in donne sopra i 50 anni. In Osservatorio Nazionale Per La Prevenzione Dei Tumori Femminili, Rosselli Del Turco M, Zappa M, pp Roma: Quarto Rapporto. 150–153
2. Bethesda NCI Workshop (1993) The Bethesda System for reporting cervical-vaginal cytologic diagnosis: revised after the second National Cancer Institute Workshop, April 29–30, 1991. Acta Cytol 37: 115–124
3. Brisson J, Morin C, Fortier M, Roy M, Bouchard C, Leclerc J, Christen A, Guimont C, Penault F, Meisels A (1994) Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. Am J Epidemiol 140: 700–710
4. Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L (2005) Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives. J Med Screen 12: 7–11
5. Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, Segnan N (1993) European guidelines for quality assurance in cervical cancer screening. Eur J Cancer 29A: S1–S37